Regulatory News
Position ：
- Deucravacitinib Tablets approved for marketing by China NMPA2023-10-24
- 3rd China Biologics CMC Conference held in Hangzhou2023-10-16
- Narlumosbart Injection approved with conditions for marketing by China NMPA2023-10-10
- Article by the GHWP Chair Dr. Xu "Promote Global Medical Device Regulations towards Conver...2023-09-26
- NMPA holds training on internal review of vaccine regulatory quality management system2023-09-26
- Tafolecimab Injection approved for marketing by China NMPA2023-09-21
- Sunvozertinib Tablets approved for marketing by China NMPA2023-09-11
- NMPA Announcement on adopting ICH Guidelines S12: Nonclinical Biodistribution Consideratio...2023-09-07
- NMPA Announcement on adopting ICH Guidelines Q12: Technical and Regulatory Considerations ...2023-09-05
- TCM compound preparation Pipa Qingfei granules approved for marketing2023-08-24